Ars Pharmaceuticals Inc (SPRY)
Long-Term Debt
$171.60M
Quarterly · Period ending: · USD
SPRY Long-Term Debt
Latest reported$171.60Mperiod ending
Latest reported$171.60Mperiod ending
SPRY Quarterly Long-Term Debt ($3.32M → $171.60M)
Quarterly long-term debt
High-resolution chart · PNG
SPRY long-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Long-Term Debt (USD) |
|---|---|
| 171,603,000 | |
| 96,522,000 | |
| 96,374,000 | |
| 949,000 | |
| 1,072,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 37,000 | |
| 92,000 | |
| 146,000 | |
| 199,000 | |
| 251,000 | |
| 2,584,000 | |
| 3,519,000 | |
| 4,431,000 | |
| 5,410,000 | |
| 5,080,000 | |
| 1,778,000 | |
| 2,055,000 | |
| 2,326,000 | |
| 3,324,000 |